Peak Fuji Finnish Sauna Study: Does the Research Apply?
← Part of the Peak Fuji evidence audit
Evidence Interpretation
Short answer: The Fuji’s page cites a roughly 40% all-cause mortality association — and encourages buyers to “live longer” — to support 150°F heat. But the research is an observational study of frequent traditional-sauna use among middle-aged Finnish men, in saunas typically far hotter than 150°F. It reports associations, not product-specific causation, and did not test the Peak Fuji or any 150°F infrared cabin. It does not directly establish the same outcome for this product.
What the study actually was
The research most often cited for the “40% lower mortality” figure is Laukkanen and colleagues’ 2015 paper in JAMA Internal Medicine:
| Feature | What the study used |
|---|---|
| Design | Prospective observational cohort (Kuopio Ischemic Heart Disease study) — not a randomized trial |
| Participants | 2,315 middle-aged men (ages 42–60) in eastern Finland |
| Follow-up | Median 20.7 years; 929 all-cause deaths recorded |
| Sauna type | Traditional Finnish sauna — not infrared |
| Typical temperature | Traditional Finnish saunas typically run ~80–90°C (about 176–194°F) — materially hotter than a 150°F infrared cabin |
The numbers behind the headline
The study reports explicit hazard ratios for its cardiovascular endpoints, comparing men with 4–7 sauna sessions/week to those with one, after adjustment for cardiovascular risk factors:
| Endpoint | Hazard ratio (95% CI) |
|---|---|
| Sudden cardiac death | 0.37 (0.18–0.75); P for trend = .005 |
| Fatal cardiovascular disease | 0.50 (0.33–0.77) |
| All-cause mortality | Similar significant inverse trend (P for trend ≤ .005); the study reports crude all-cause death rates falling from 49.1% to 37.8% to 30.8% across the three frequency groups — the basis for the “~40% lower” relative-reduction headline |
Two cautions on those numbers. First, the “40%” is a relative reduction between frequency groups, which corresponds to a smaller absolute difference across the cohort. Second, the paper reports the explicit hazard ratios above for sudden cardiac death and fatal CVD; for all-cause mortality it reports a significant inverse trend rather than a single headline HR, which is why we present the group rates rather than inventing one.
Three reasons the finding doesn’t map onto the Fuji
1. It’s observational, so it shows association, not causation
A cohort study can show that frequent sauna users lived longer; it cannot prove the sauna caused the difference. Frequent users may differ in other ways — leisure time, baseline health, lifestyle — and the journal’s own editorial at the time noted this uncertainty about mechanism. The authors adjusted for known cardiovascular risk factors, which strengthens the association, but association from observational data is not a demonstrated product benefit.
2. It studied a hotter, different heat modality
The saunas were traditional Finnish saunas at roughly 176–194°F, where bathers pour water on heated rocks — a different thermal environment from a 150°F infrared cabin. The dose-response observed at ~180°F traditional heat cannot be assumed to hold at 150°F infrared.
3. It never tested the Fuji — or any infrared sauna
No infrared product, and certainly not the Peak Fuji, was part of the study.
The honest way to cite this research
The study is a legitimate, widely respected piece of evidence that regular heat exposure is associated with better cardiovascular and all-cause mortality outcomes in the population studied. The accurate framing is narrow: the study does not directly establish the same outcome for lower-temperature infrared saunas or the Fuji specifically. What crosses the line is pairing the 40% figure with a “live longer” promise attached to a particular 150°F infrared cabin, as though the study measured that product.
Frequently asked questions
Did a study prove saunas cut mortality by 40 percent?
A 2015 observational cohort study of middle-aged Finnish men found that using a traditional sauna 4 to 7 times a week was associated with about 40% lower all-cause mortality versus once a week. Associated with is the key phrase; observational studies show associations, not proof of cause, and the 40% is a relative reduction. The study used traditional saunas, not infrared.
Does that study apply to the Peak Fuji or infrared saunas?
Not directly. The study used traditional Finnish saunas at roughly 176 to 194F, not a 150F infrared cabin, and it did not test the Fuji or any infrared product. It does not directly establish the same outcome for a lower-temperature infrared sauna or the Fuji specifically.
What are the actual hazard ratios in the study?
For men with 4 to 7 sessions a week versus one, the adjusted hazard ratio was 0.37 (95% CI 0.18 to 0.75) for sudden cardiac death and 0.50 (95% CI 0.33 to 0.77) for fatal cardiovascular disease. All-cause mortality showed a similar significant inverse trend, with crude death rates falling from 49.1% to 30.8% across frequency groups.
Sources
- Laukkanen T, Khan H, Zaccardi F, Laukkanen JA. “Association Between Sauna Bathing and Fatal Cardiovascular and All-Cause Mortality Events.” JAMA Internal Medicine, 2015;175(4):542–548. PMID 25705824; doi:10.1001/jamainternmed.2014.8187.
- Redberg RF. “Health benefits of sauna bathing” (editorial). JAMA Internal Medicine, 2015;175(4):548. doi:10.1001/jamainternmed.2014.8206.
- Peak Saunas — Fuji product page, health/longevity language (manufacturer, reviewed July 17, 2026).